Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH

• Egile Nagusiak: Mizrahi M (Egilea), Shabat Y (Egilea), Ben Ya'acov A (Egilea), Lalazar G (Egilea), Adar T (Egilea), Wong V (Egilea), Muller B (Egilea), Rawlin G (Egilea), Ilan Y (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2012-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Meir Mizrahi,1 Yehudit Shabat,1 Ami Ben Ya'acov,1 Gadi Lalazar,1 Tomer Adar,1 Victor Wong,2 Brian Muller,2 Grant Rawlin,2 Yaron Ilan11Liver Unit, Hebrew University-Hadassah Medical Center, Jerusalem, Israel; 2Immuron Limited, North Melbourne, AustraliaBackground: Nonalcoholic steatohepatitis...